Dr. Melissa E. Middeldorp earned her PhD in 2019 from the University of Adelaide, where her thesis explored risk factors, disease progression, and sex-based differences in AF patients.
In 2022, Dr. Middeldorp completed a Master of Public Health at Harvard University, enhancing her expertise in epidemiology and public health. She subsequently undertook a postdoctoral fellowship at Cedars-Sinai Medical Center in Los Angeles and the University Medical Center Groningen in the Netherlands, focusing on AF epidemiology.
Her research emphasizes individualized, structured clinics for managing cardiovascular risk factors in AF patients, aiming to improve symptoms and outcomes. Additionally, she investigates gender disparities in AF outcomes, digital health, and treatment strategies.
Dr. Middeldorp has contributed to significant peer-reviewed publications and regularly speaks overseas at major international conferences. She is also involved in supervising postgraduate students and continues to contribute to the advancement of cardiovascular research and patient care strategies.